20th Anniversary Special - Episode #13 Monoclonal Antibodies - Part 1
Howard Levine, PhD
President, BioProcess Technology Consultants
BioPharmNow Interview
Subscribe to the Podcast
Interview: Howard Levine, PhD, the President of BioProcess Technology Consultants, a consulting firm specializing in biopharmaceutical process development, manufacturing, and engineering.
Listen to BioPharm International’s Managing Editor Chitra Sethi interview Howard Levine on the recent advances in monoclonal antibody therapeutic development.
This is part one of a two-part podcast.
In this episode, Dr. Levine discusses the advantages of fully-human MAbs, the development of MAb fragments, and how to accelerate the process of cell line selection.
Click on the RSS Icon to subscribe to all BioPharmNow podcasts with your installed reader.
If you don't have an RSS reader installed yet, here are some options:
BiopharmNow podcasts are developed and produced by BIOPHARMINTERNATIONAL.COM, a division of Advanstar Communications, Inc., which is solely responsible for podcast content.
